Truist: 'We Remain Bullish on Addus HomeCare (ADUS)'

Truist Securities analyst Clarke Murphy reiterated a Buy rating and $135.00 price target on Addus HomeCare (NASDAQ: ADUS).

The analyst commented: "We remain bullish on ADUS following solid 4Q results with better margins and strong growth in Personal Care and Hospice and HH improvement initiatives underway. We see plenty of opportunity in PC given rate momentum (IL, TX, upbeat commentary on NM), largely solid labor trends and improved census expected in ’26 while we like ADUS’ positioning around regulatory given historical investments in compliance. ADUS' strong balance sheet and low leverage provide attractive footing to execute across segments while supporting ongoing growth investment and M&A in an environment where we continue to see opportunity. We reiterate our Buy rating and $135 PT, estimates bumped."

For an analyst ratings summary and ratings history on Addus HomeCare click here. For more ratings news on Addus HomeCare click here.

Shares of Addus HomeCare closed at $105.20 yesterday.

You May Also Be Interested In

• Goldman Sachs Starts Excelerate Energy Inc (EE) at Buy
• Raymond James Resumes CubeSmart (CUBE) at Outperform
• Gladstone Land authorizes up to $55M preferred stock buyback